Publication | Open Access

Design, rationale, and baseline characteristics of the randomized double-blind phase II clinical trial of ibudilast in progressive multiple sclerosis

Neurological DisorderClinical NeurologyClinical TrialsNeurological ProgressProgressive Multiple SclerosisBaseline CharacteristicsNeurologyMultiple SclerosisMedicine